fingolimod hydrochloride has been researched along with Body Weight in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (4.76) | 18.2507 |
2000's | 14 (66.67) | 29.6817 |
2010's | 6 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lv, L; Qian, J; Ye, S; Ye, Y; Zhu, C | 1 |
Armida, M; De Simone, R; Mazziotti, V; Minghetti, L; Pèzzola, A; Popoli, P; Potenza, RL | 1 |
Bidadkosh, A; Buikema, H; Deelman, LE; Hamidi Shishavan, M; Henning, RH; Lambooy, S; van den Born, J; Yazdani, S | 1 |
Dikow, R; Gross, ML; Hug, F; Schaier, M; Sommerer, C; Vorwalder, S; Waldherr, R; Zeier, M | 1 |
Bergonzini, V; Costa, S; Galletti, M; Nofer, JR; Pignatti, E; Poti, F; Simoni, M; Weber, C | 1 |
Chen, X; Li, J; Lu, Y; Wan, H; Ye, S; Zhang, S; Zheng, G; Zhu, H | 1 |
Choi, J; Chon, J; In, J; Joo, J; Kim, D; Lee, H; Moon, H; Park, J | 1 |
Gottschalk, R; Maki, T; Monaco, AP | 1 |
Kawachi, H; Krämer, S; Martini, S; Neumayer, HH; Peters, H; Shimizu, F; Wang, Y | 1 |
Itoh, M; Kataoka, H; Kuno, A; Nakao, H; Ogawa, K; Ohara, H; Okamoto, T; Sano, H; Shirai, T; Tang, M; Yamada, T | 1 |
Chan, FL; Chua, CW; Ho, J; Lee, DT; Ling, MT; Man, K; Wang, X; Wong, YC; Zhou, C | 1 |
Ito, T; Matsuda, C; Matsuda, H; Miao, G; Nishida, T; Nozawa, M; Sawa, Y; Song, J; Tanemura, M | 1 |
Bueno, V; Burdmann, EA; Cury, PM; Silva, FR; Silva, LB | 1 |
Budde, K; Daig, U; Krämer, S; Loof, T; Martini, S; Neumayer, HH; Peters, H; Wang-Rosenke, Y | 1 |
Balatoni, B; Foster, CA; Hiestand, PC; Koziel, A; Lambrou, GN; Schönborn, V; Storch, MK; Swoboda, EM; Weissert, R | 1 |
Fauser, U; Schluesener, HJ; Zhang, Z; Zhang, ZY | 1 |
Fujimura, A; Hozumi, Y; Kobayashi, E; Miyata, M | 1 |
Hikita, N; Ikeda, E; Kurose, S; Mochizuki, M; Tokiwa, M | 1 |
Isobe, M; Kitabayashi, H; Sekiguchi, M; Suzuki, J; Watanabe, N; Yazaki, Y | 1 |
Baumlin, Y; Hof, A; Hof, RP; Nikolova, Z | 2 |
21 other study(ies) available for fingolimod hydrochloride and Body Weight
Article | Year |
---|---|
FTY720 attenuates paraquat-induced lung injury in mice.
Topics: Actins; Acute Lung Injury; Animals; Body Weight; Bronchoalveolar Lavage Fluid; Collagen Type I; Collagen Type III; Disease Models, Animal; Fingolimod Hydrochloride; Interleukin-1beta; Interleukin-6; Lung; Lung Injury; Mice; Mice, Inbred C57BL; Paraquat; Propylene Glycols; Pulmonary Edema; Pulmonary Fibrosis; Sphingosine; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2014 |
Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Body Weight; Brain; Cytokines; Disease Models, Animal; Fingolimod Hydrochloride; Forkhead Transcription Factors; Gene Expression Regulation; Humans; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Mice, Transgenic; Movement Disorders; Mutation; Nitric Oxide Synthase Type II; Spinal Cord; Superoxide Dismutase | 2016 |
Differential Effects of Long Term FTY720 Treatment on Endothelial versus Smooth Muscle Cell Signaling to S1P in Rat Mesenteric Arteries.
Topics: Animals; Body Weight; Endothelial Cells; Fingolimod Hydrochloride; Gene Expression Regulation; Hemodynamics; Humans; Lysophospholipids; Male; Mesenteric Arteries; Muscle Development; Myocytes, Smooth Muscle; Pressure; Rats; Rats, Wistar; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Time Factors; Vasoconstriction | 2016 |
Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats.
Topics: Administration, Oral; Albuminuria; Animals; Blood Pressure; Body Weight; Chemokine CCL2; Chemokine CCL5; Chemokines; Creatinine; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Fibronectins; Fibrosis; Fingolimod Hydrochloride; Gene Expression Regulation; Immunosuppressive Agents; Inflammation Mediators; Kidney; Kidney Failure, Chronic; Lymphocytes; Macrophages; Male; Nephrectomy; Nephritis; Phenotype; Propylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, CCR1; Receptors, CCR2; Receptors, CCR5; Sphingosine; Time Factors; Transforming Growth Factor beta1 | 2009 |
Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Atherosclerosis; Body Weight; CD11b Antigen; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Fingolimod Hydrochloride; Genes, MHC Class II; Indans; Interleukin-2; Interleukin-6; Lymph Nodes; Lymphocyte Activation; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Oxadiazoles; Proprotein Convertases; Propylene Glycols; Receptors, LDL; Receptors, Lysosphingolipid; Serine Endopeptidases; Sphingosine; Spleen | 2012 |
Effect of FTY720 on some physiological indexes of Non-Obese Diabetic (NOD) Mice.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Fingolimod Hydrochloride; Glutamate Decarboxylase; Immunosuppressive Agents; Kidney; Liver; Mice; Mice, Inbred NOD; Propylene Glycols; Sphingosine; Spleen | 2012 |
FTY720 preserved islet β-cell mass by inhibiting apoptosis and increasing survival of β-cells in db/db mice.
Topics: Animals; Apoptosis; Blood Glucose; Body Weight; Cell Survival; Diabetes Mellitus, Type 2; Female; Fingolimod Hydrochloride; Glucose Tolerance Test; Immunosuppressive Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Mice; Propylene Glycols; Sphingosine | 2013 |
Prevention of autoimmune diabetes by FTY720 in nonobese diabetic mice.
Topics: Animals; Body Weight; Cyclophosphamide; Diabetes Mellitus, Type 1; Female; Fingolimod Hydrochloride; Graft Rejection; Immunosuppressive Agents; Islets of Langerhans Transplantation; Mice; Mice, Inbred NOD; Propylene Glycols; Sphingosine | 2002 |
Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis.
Topics: Animals; Blood Pressure; Blood Urea Nitrogen; Body Weight; Creatinine; Extracellular Matrix; Fibrosis; Fingolimod Hydrochloride; Glomerulosclerosis, Focal Segmental; Heart Rate; Immunosuppressive Agents; Isoantibodies; Lymphocyte Count; Lymphocytes; Male; Propylene Glycols; Proteinuria; Rats; Rats, Wistar; Sphingosine | 2004 |
FTY720, an immunosuppressant, attenuates chronic pancreatitis in rats by suppressing T-cell infiltration.
Topics: Animals; Body Weight; Fingolimod Hydrochloride; Hydroxyproline; Immunosuppressive Agents; Interferon-gamma; Male; Organ Size; Pancreas; Pancreatitis, Chronic; Peroxidase; Propylene Glycols; Rats; Rats, Wistar; RNA, Messenger; Sphingosine; T-Lymphocytes; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
FTY720, a fungus metabolite, inhibits in vivo growth of androgen-independent prostate cancer.
Topics: Androgens; Animals; Apoptosis; beta Catenin; Body Weight; Cadherins; Caspase 3; Caspases; Cell Division; Fingolimod Hydrochloride; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Male; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Orchiectomy; Platelet Endothelial Cell Adhesion Molecule-1; Propylene Glycols; Prostate-Specific Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Sphingosine; Vascular Endothelial Growth Factor A | 2005 |
Inhibition of donor-derived T cells trafficking into target organs by FTY720 during acute graft-versus-host disease in small bowel transplantation.
Topics: Acute Disease; Animals; Body Weight; Cytokines; Fingolimod Hydrochloride; Graft vs Host Disease; Immunosuppressive Agents; Intestine, Small; Liver; Lymphocyte Count; Male; Propylene Glycols; Rats; Rats, Inbred WF; Skin; Sphingosine; T-Lymphocyte Subsets; Transplantation Chimera | 2006 |
FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
Topics: Animals; Body Weight; Cell Count; Creatinine; Cyclosporine; Drug Therapy, Combination; Fingolimod Hydrochloride; Graft Survival; Histocompatibility Antigens Class II; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Kidney; Lymph Nodes; Lymphocyte Count; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Potassium; Propylene Glycols; Skin Transplantation; Sodium; Sphingosine; Spleen; Transplantation, Homologous | 2006 |
S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
Topics: Animals; Antibodies, Blocking; Blood Pressure; Body Weight; Collagen Type III; Extracellular Matrix; Fibronectins; Fingolimod Hydrochloride; Glomerulonephritis, Membranoproliferative; Heart Rate; Immunohistochemistry; Kidney Glomerulus; Leukocyte Count; Lipopolysaccharides; Male; Nitric Oxide Synthase Type II; Plasminogen Activator Inhibitor 1; Propylene Glycols; Proteinuria; Rats; Rats, Wistar; Receptors, Lysosphingolipid; Sphingosine; Thy-1 Antigens; Transforming Growth Factor beta | 2007 |
FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis.
Topics: Analysis of Variance; Animals; Body Weight; Disease Models, Animal; Electric Stimulation; Encephalomyelitis, Autoimmune, Experimental; Evoked Potentials, Somatosensory; Evoked Potentials, Visual; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Longitudinal Studies; Myelin Proteins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Neural Conduction; Propylene Glycols; Rats; Reaction Time; Sphingosine; Spinal Cord; Time Factors | 2007 |
FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves.
Topics: Animals; Body Weight; CD3 Complex; Disease Models, Animal; Ectodysplasins; Fingolimod Hydrochloride; Flow Cytometry; Immunosuppressive Agents; Lymphocytes; Macrophages; Male; Neuritis, Autoimmune, Experimental; Propylene Glycols; Rats; Rats, Inbred Lew; Sciatic Nerve; Sphingosine; Sulfonamides | 2008 |
Immunotherapy for experimental rat autoimmune thyroiditis using a novel immunosuppressant, FTY720.
Topics: Animals; Body Weight; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Liver; Organ Size; Propylene Glycols; Rats; Sphingosine; Spleen; Thyroid Gland; Thyroiditis, Autoimmune; Thyrotropin | 1999 |
Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats.
Topics: Animals; Antibodies; Arrestin; Autoimmune Diseases; Blood Cell Count; Body Weight; Chi-Square Distribution; Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Immunosuppressive Agents; Male; Propylene Glycols; Rats; Rats, Inbred Lew; Retinitis; Sphingosine; Statistics, Nonparametric; T-Lymphocytes; Uveitis | 2000 |
FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes.
Topics: Analysis of Variance; Animals; Autoimmune Diseases; Body Weight; Fingolimod Hydrochloride; Immunosuppressive Agents; Injections, Intraperitoneal; Lymphocyte Count; Lymphocytes; Male; Myocarditis; Organ Size; Propylene Glycols; Rats; Rats, Inbred Lew; Sphingosine; Tacrolimus | 2000 |
The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD.
Topics: Animals; Body Weight; Drug Therapy, Combination; Everolimus; Fingolimod Hydrochloride; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Lymphocyte Count; Male; Myocardium; Propylene Glycols; Rats; Rats, Inbred Lew; Sirolimus; Sphingosine; Transplantation, Heterotopic | 2000 |
Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.
Topics: Adjuvants, Immunologic; Animals; Body Weight; Cyclosporine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Fingolimod Hydrochloride; Graft Rejection; Graft Survival; Heart Transplantation; Histocompatibility Antigens; Immunosuppressive Agents; Lymphocyte Count; Male; Models, Animal; Propylene Glycols; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Skin Transplantation; Sphingosine | 2001 |